These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 8504218)

  • 21. Emerging principles for the recognition of peptide antigens by MHC class I molecules.
    Matsumura M; Fremont DH; Peterson PA; Wilson IA
    Science; 1992 Aug; 257(5072):927-34. PubMed ID: 1323878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural implications for the design of molecular vaccines.
    Apostolopoulos V; Yu M; McKenzie IF; Wilson IA
    Curr Opin Mol Ther; 2000 Feb; 2(1):29-36. PubMed ID: 11249650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. pH dependence of MHC class I-restricted peptide presentation.
    Stryhn A; Pedersen LO; Romme T; Olsen AC; Nissen MH; Thorpe CJ; Buus S
    J Immunol; 1996 Jun; 156(11):4191-7. PubMed ID: 8666787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting peptide binding to Major Histocompatibility Complex molecules.
    Liao WW; Arthur JW
    Autoimmun Rev; 2011 Jun; 10(8):469-73. PubMed ID: 21333759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis.
    Chang HC; Smolyar A; Spoerl R; Witte T; Yao Y; Goyarts EC; Nathenson SG; Reinherz EL
    J Mol Biol; 1997 Aug; 271(2):278-93. PubMed ID: 9268659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consensus motifs and peptide ligands of MHC class I molecules.
    Falk K; Rötzschke O
    Semin Immunol; 1993 Apr; 5(2):81-94. PubMed ID: 7684938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune recognition of viral antigens.
    Wilson IA; Stanfield RL; Jewell DA; Ghiara JB; Fremont DH; Stura EA
    Infect Agents Dis; 1994; 3(2-3):155-62. PubMed ID: 7812653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformation of MHC class II I-A(g7) is sensitive to the P9 anchor amino acid in bound peptide.
    Gardiner A; Richards KA; Sant AJ; Arneson LS
    Int Immunol; 2007 Sep; 19(9):1103-13. PubMed ID: 17855434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential role of conserved and polymorphic residues of the binding groove of MHC class I molecules in the selection of peptides.
    Abastado JP; Casrouge A; Kourilsky P
    J Immunol; 1993 Oct; 151(7):3569-75. PubMed ID: 8376793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A negatively charged anchor residue promotes high affinity binding to the MHC class II molecule I-Ak.
    Nelson CA; Viner NJ; Young SP; Petzold SJ; Unanue ER
    J Immunol; 1996 Jul; 157(2):755-62. PubMed ID: 8752926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-dimensional structure of a peptide extending from one end of a class I MHC binding site.
    Collins EJ; Garboczi DN; Wiley DC
    Nature; 1994 Oct; 371(6498):626-9. PubMed ID: 7935798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Qa-2 molecules are peptide receptors of higher stringency than ordinary class I molecules.
    Rötzschke O; Falk K; Stevanović S; Grahovac B; Soloski MJ; Jung G; Rammensee HG
    Nature; 1993 Feb; 361(6413):642-4. PubMed ID: 8437623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The optimization of peptide cargo bound to MHC class I molecules by the peptide-loading complex.
    Elliott T; Williams A
    Immunol Rev; 2005 Oct; 207():89-99. PubMed ID: 16181329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative aspects of T cell activation--peptide generation and editing by MHC class I molecules.
    Stevanović S; Schild H
    Semin Immunol; 1999 Dec; 11(6):375-84. PubMed ID: 10625591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations.
    Chen Y; Sidney J; Southwood S; Cox AL; Sakaguchi K; Henderson RA; Appella E; Hunt DF; Sette A; Engelhard VH
    J Immunol; 1994 Mar; 152(6):2874-81. PubMed ID: 8144888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decamer-like conformation of a nona-peptide bound to HLA-B*3501 due to non-standard positioning of the C terminus.
    Menssen R; Orth P; Ziegler A; Saenger W
    J Mol Biol; 1999 Jan; 285(2):645-53. PubMed ID: 9878435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell recognition of MHC class II-associated peptides is independent of peptide affinity for MHC and sodium dodecyl sulfate stability of the peptide/MHC complex. Effects of conservative amino acid substitutions at anchor position 1 of influenza matrix protein19-31.
    Wu S; Gorski J; Eckels DD; Newton-Nash DK
    J Immunol; 1996 May; 156(10):3815-20. PubMed ID: 8621918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naturally processed HLA class I bound peptides from c-myc-transfected cells reveal allele-specific motifs.
    Harris PE; Colovai A; Liu Z; Dalla Favera R; Suciu-Foca N
    J Immunol; 1993 Dec; 151(11):5966-74. PubMed ID: 8245441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions between immunogenic peptides and MHC proteins.
    Rothbard JB; Gefter ML
    Annu Rev Immunol; 1991; 9():527-65. PubMed ID: 1910688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.